Beyond the Buzz: Dissecting Recursion Pharmaceuticals and NuScale Power in a 'Lightning Round'
The Evolving Landscape of Biotech Innovation and Investment
The Human Face of AI: How Recursion Pharma and Najat Khan Are Redefining Drug Discovery